On June 28, 2021, Japan MHLW updated the FAQs about the Approval for Quasi-drugs, which replaced the previous FAQs and came into effect on the date of promulgation. The updated FAQs clarifies the marketing/manufacturing approval of quasi-drugs, testing, quasi-drugs standards, etc. It includes 75 questions, among which Q47, Q48, Q53, Q54, Q74 and Q75 were newly-added questions.